Core Viewpoint - An investor engaged in abnormal trading behavior to manipulate the stock price of Chicheng Co., leading to significant market impact and subsequent regulatory action [1][3][6]. Group 1: Abnormal Trading Behavior - On December 18, 2025, the investor's account exhibited abnormal trading activities, including price manipulation of Chicheng Co. shares, which resulted in a 30% increase in stock price on that day [2][3]. - Specific trading activities included significant buying volumes during short time frames, with one instance showing a price increase of 5.62% while buying 54,400 shares worth 1.73 million yuan, accounting for 32.13% of total transactions [5]. - The investor's actions led to a situation where the stock price reached its upper limit, triggering abnormal volatility as defined by trading regulations [5]. Group 2: Regulatory Actions - The investor, identified as Li Mouhao, had a history of abnormal trading and had previously faced self-regulatory measures, including account trading suspensions on June 20 and November 7, 2025 [6]. - Following the December 18 incident, the Beijing Stock Exchange imposed a three-month trading restriction on Li's account, effective from December 19, 2025, to March 18, 2026, and recorded this in the securities market integrity archive [6]. - The exchange's decision was based on violations of trading rules, specifically regarding large and continuous orders that deviated significantly from market prices [5][6]. Group 3: Company Response - Chicheng Co. issued a statement acknowledging the abnormal trading fluctuations, noting that the cumulative price deviation over the three trading days leading up to December 18 was 41.17% [7]. - The company's board confirmed that there were no undisclosed matters that could have influenced the stock price, adhering to the disclosure requirements set by the Beijing Stock Exchange [7].

Core Viewpoint - Zhejiang Haokun Shengfa Asset Management Co., Ltd. has been issued a warning letter by the Zhejiang Securities Regulatory Bureau due to multiple violations, including unfair treatment of different fund assets and misleading promotional materials for private funds [1][2][3] Group 1: Violations and Regulatory Actions - The company has been found to engage in unfair treatment of different fund assets, misleading statements in promotional materials, and reverse trading without decision-making records [2][3] - The legal representative and general manager, Zhang Menfa, along with the actual management personnel and fund manager, Ge Zhongfu, have also received warning letters as part of supervisory measures [1][3] - These actions violate the "Interim Measures for the Supervision and Administration of Private Investment Funds," leading to the issuance of a warning letter and recording in the securities and futures market integrity archive [3] Group 2: Market Manipulation Concerns - The behavior of price manipulation through intra-day price lifting and suppression is considered market manipulation, which undermines the principles of fairness and transparency in the market [4] - Such actions distort market pricing mechanisms, mislead investor decisions, and can lead to unnecessary losses for investors [4] - Regulatory measures are suggested to enhance monitoring through technology, utilizing big data to track fund movements, and increasing administrative penalties and criminal accountability [4] Group 3: Fund Performance and Holdings - In the third quarter, multiple products from Zhejiang Haokun Shengfa Asset appeared among the top ten circulating shareholders of several stocks on the Beijing Stock Exchange, including Jiahua Technology and Henghe Shares [5][6] - Specific holdings include 727,500 shares in Hongyu Packaging and significant positions in Jin Hao Medical, which has seen a price increase of over 203% this year [6]